Transcriptomic characteristics of bronchoalveolar lavage fluid and peripheral blood mononuclear cells in COVID-19 patients

Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2

Love, M. I., Huber, W., & Anders, S. (2014) · Genome Biology · doi:10.1186/s13059-014-0550-8 · Cited by 95,106

STAR: ultrafast universal RNA-seq aligner

Dobin, A., Davis, C. A., Schlesinger, F., Drenkow, J., Zaleski, C., Jha, S., Batut, P., Chaisson, M., & Gingeras, T. R. (2013) · Bioinformatics · doi:10.1093/bioinformatics/bts635 · Cited by 51,709

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884

clusterProfiler: an R Package for Comparing Biological Themes Among Gene Clusters

Yu, G., Wang, L.-G., Han, Y., & He, Q.-Y. (2012) · OMICS: A Journal of Integrative Biology · doi:10.1089/omi.2011.0118 · Cited by 36,259

Clinical characteristics of coronavirus disease 2019 in China

Guan, W.-J., Ni, Z.-Y., Hu, Y., Liang, W.-H., Ou, C.-Q., He, J.-X., Liu, L., Shan, H., Lei, C.-L., Hui, D. S. C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2002032 · Cited by 30,246

featureCounts: an efficient general purpose program for assigning sequence reads to genomic features

Liao, Y., Smyth, G. K., & Shi, W. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btt656 · Cited by 27,219

A pneumonia outbreak associated with a new coronavirus of probable bat origin

Zhou, P., Yang, X.-L., Wang, X.-G., Hu, B., Zhang, L., Zhang, W., Si, H.-R., Zhu, Y., Li, B., Huang, C.-L., et al. (2020) · Nature · doi:10.1038/s41586-020-2012-7 · Cited by 21,969

Epidemiological and clinical characteristics of 99 cases of 2019 novel Coronavirus pneumonia in Wuhan, China: a descriptive study.

Chen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., Qiu, Y., Wang, J., Liu, Y., Wei, Y., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30211-7 · Cited by 21,415

Clinical characteristics of 138 hospitalized patients with 2019 Novel Coronavirus-Infected pneumonia in Wuhan, China

Wang, D., Hu, B., Hu, C., Zhu, F., Liu, X., Zhang, J., Wang, B., Xiang, H., Cheng, Z., Xiong, Y., et al. (2020) · JAMA · doi:10.1001/jama.2020.1585 · Cited by 20,148

La certeza de lo impredecible: Cultura Educación y Sociedad en tiempos de COVID19

Martínez González, M. (2020) · DSPACE System - Metalibrary (University of the Coast) · Cited by 18,463

The cytokine storm in COVID-19: an overview of the involvement of the chemokine/chemokine-receptor system

Coperchini, F., Chiovato, L., Croce, L., Magri, F., & Rotondi, M. (2020) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2020.05.003 · Cited by 1,288

COVID-19 severity correlates with airway epithelium–immune cell interactions identified by single-cell analysis

Chua, R. L., Lukassen, S., Trump, S., Hennig, B. P., Wendisch, D., Pott, F., Debnath, O., Thürmann, L., Kurth, F., Völker, M. T., et al. (2020) · Nature Biotechnology · doi:10.1038/s41587-020-0602-4 · Cited by 1,035

SARS-CoV-2 infection: The role of cytokines in COVID-19 disease

Costela-Ruiz, V. J., Montes, R. I., Puerta, J. M., Ruíz, C., & Melguizo‐Rodríguez, L. (2020) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2020.06.001 · Cited by 1,132

Immune response to SARS‐CoV‐2 and mechanisms of immunopathological changes in COVID‐19

Azkur, A. K., Akdiş, M., Azkur, D., Sokołowska, M., van de Veen, W., Brüggen, M., O’Mahony, L., Gao, Y., Nadeau, K. C., & Akdiş, C. A. (2020) · Allergy · doi:10.1111/all.14364 · Cited by 1,149

Cytokine Storm in COVID-19: The Current Evidence and Treatment Strategies

Tang, Y., Liu, J., Zhang, D., Xu, Z., Ji, J., & Wen, C. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01708 · Cited by 1,094

Anti-Inflammatory Effects of Curcumin in the Inflammatory Diseases: Status, Limitations and Countermeasures

Peng, Y., Ao, M., BaoHua, D., Jiang, Y., Yu, L., Chen, Z., Hu, C.-J., & Xu, R. (2021) · Drug Design Development and Therapy · doi:10.2147/dddt.s327378 · Cited by 916

Cytokine storm and leukocyte changes in mild versus severe SARS-CoV-2 infection: Review of 3939 COVID-19 patients in China and emerging pathogenesis and therapy concepts

Wang, J., Jiang, M., Chen, X., & Montaner, L. J. (2020) · Journal of Leukocyte Biology · doi:10.1002/jlb.3covr0520-272r · Cited by 748

Immune response, inflammation, and the clinical spectrum of COVID-19

García, L. F. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01441 · Cited by 739

COVID-19 and the human innate immune system

Schultze, J. L., & Aschenbrenner, A. C. (2021) · Cell · doi:10.1016/j.cell.2021.02.029 · Cited by 714

Should we stimulate or suppress immune responses in COVID-19? Cytokine and anti-cytokine interventions

Jamilloux, Y., Henry, T., Bélot, A., Viel, S., Fauter, M., Jammal, T. E., Walzer, T., François, B., & Sève, P. (2020) · Autoimmunity Reviews · doi:10.1016/j.autrev.2020.102567 · Cited by 663

An Update on Current Therapeutic Drugs Treating COVID-19

Wu, R., Wang, L., Kuo, H. D., Shannar, A., Peter, R. M., Chou, P. J., Li, S. N., Hudlikar, R. R., Liu, X., Liu, Z., et al. (2020) · Current Pharmacology Reports · doi:10.1007/s40495-020-00216-7 · Cited by 600

Coagulopathy of Coronavirus Disease 2019

Iba, T., Levy, J. H., Levi, M. M., Connors, J. M., & Thachil, J. V. (2020) · Critical Care Medicine · doi:10.1097/ccm.0000000000004458 · Cited by 541

Immunopathology of Hyperinflammation in COVID-19

Gustine, J. N., & Jones, D. (2021) · The American Journal of Pathology · doi:10.1016/j.ajpath.2020.08.009 · Cited by 516

Association of COVID-19 inflammation with activation of the C5a–C5aR1 axis

Carvelli, J., Demaria, O., Vély, F., Batista, L., Chouaki Benmansour, N., Fares, J., Carpentier, S., Thibult, M.-L., Morel, A., Remark, R., et al. (2020) · Nature · doi:10.1038/s41586-020-2600-6 · Cited by 526

The COVID-19 puzzle: deciphering pathophysiology and phenotypes of a new disease entity

Osuchowski, M. F., Winkler, M. S., Skirecki, T., Cajander, S., Shankar‐Hari, M., Lachmann, G., Monneret, G., Venet, F., Bauer, M. W., Brunkhorst, F. M., et al. (2021) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(21)00218-6 · Cited by 528

Overview of Immune Response During SARS-CoV-2 Infection: Lessons From the Past

Shah, V. K., Firmal, P., Alam, A., Ganguly, D., & Chattopadhyay, S. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01949 · Cited by 476

Interplay between SARS-CoV-2 and the type I interferon response

Sa Ribero, M., Jouvenet, N., Dreux, M., & Nisole, S. (2020) · PLOS Pathogens · doi:10.1371/journal.ppat.1008737 · Cited by 443

COVID19 coagulopathy in Caucasian patients

Fogarty, H., Townsend, L., Cheallaigh, C. N., Bergin, C. J., Martín‐Loeches, I., Browne, P., Bacon, C. L., Gaule, R., Gillett, A., Byrne, M., et al. (2020) · British Journal of Haematology · doi:10.1111/bjh.16749 · Cited by 418

SARS-CoV-2 spike protein induces inflammation via TLR2-dependent activation of the NF-κB pathway

Khan, S., Shafiei, M. S., Longoria, C., Schoggins, J. W., Savani, R. C., & Zaki, H. (2021) · eLife · doi:10.7554/elife.68563 · Cited by 421

The emerging spectrum of cardiopulmonary pathology of the coronavirus disease 2019 (COVID-19): Report of 3 autopsies from Houston, Texas, and review of autopsy findings from other United States cities

Buja, L. M., Wolf, D. A., Zhao, B., Akkanti, B. H., McDonald, M. M., Lelenwa, L. C., Reilly, N., Giulia Ottaviani, M., Elghetany, M. T., Trujillo, D. O., et al. (2020) · Cardiovascular Pathology · doi:10.1016/j.carpath.2020.107233 · Cited by 392

Single-Cell Sequencing of Peripheral Mononuclear Cells Reveals Distinct Immune Response Landscapes of COVID-19 and Influenza Patients

Zhu, L., Yang, P., Zhao, Y., Zhuang, Z., Wang, Z., Song, R., Zhang, J., Liu, C., Gao, Q., Xu, Q., et al. (2020) · Immunity · doi:10.1016/j.immuni.2020.07.009 · Cited by 379

Virus-Host Interactome and Proteomic Survey Reveal Potential Virulence Factors Influencing SARS-CoV-2 Pathogenesis

Li, J., Guo, M., Tian, X., Wang, X., Yang, X., Wu, P., Liu, C., Xiao, Z., Qu, Y., Yin, Y., et al. (2020) · Med · doi:10.1016/j.medj.2020.07.002 · Cited by 361

COVID-19: towards understanding of pathogenesis

Cao, W., & Li, T. (2020) · Cell Research · doi:10.1038/s41422-020-0327-4 · Cited by 344

Highlight of Immune Pathogenic Response and Hematopathologic Effect in SARS-CoV, MERS-CoV, and SARS-Cov-2 Infection

Liang, Y., Wang, M., Chien, C., Yarmishyn, A. A., Yang, Y.-P., Lai, W.-Y., Luo, Y., Lin, Y.-T., Chen, Y.-J., Chang, P., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01022 · Cited by 347

Lymphopenia during the COVID-19 infection: What it shows and what can be learned

Tavakolpour, S., Rakhshandehroo, T., Wei, E. X., & Rashidian, M. (2020) · Immunology Letters · doi:10.1016/j.imlet.2020.06.013 · Cited by 336

The pro-inflammatory cytokines in COVID-19 pathogenesis: What goes wrong?

Darif, D., Hammi, I., Kihel, A., Saik, I. E. I., Guessous, F., & Akarid, K. (2021) · Microbial Pathogenesis · doi:10.1016/j.micpath.2021.104799 · Cited by 340

Transcriptomic profiling of SARS-CoV-2 infected human cell lines identifies HSP90 as target for COVID-19 therapy

Wyler, E., Mösbauer, K., Franke, V., Diag, A., Gottula, L. T., Arsiè, R., Klironomos, F., Koppstein, D., Hönzke, K., Ayoub, S., et al. (2021) · iScience · doi:10.1016/j.isci.2021.102151 · Cited by 310

Autoinflammatory and autoimmune conditions at the crossroad of COVID-19

Rodríguez, Y., Novelli, L., Rojas, M., Santis, M. D., Acosta‐Ampudia, Y., Monsalve, D. M., Ramírez-Santana, C., Costanzo, A., Ridgway, W. M., Ansari, A. A., et al. (2020) · Journal of Autoimmunity · doi:10.1016/j.jaut.2020.102506 · Cited by 319

Severe immunosuppression and not a cytokine storm characterizes COVID-19 infections

Remy, K. E., Mazer, M. B., Striker, D. A., Ellebedy, A. H., Walton, A. H., Unsinger, J., Blood, T. M., Mudd, P. A., Yi, D. J., Mannion, D. A., et al. (2020) · JCI Insight · doi:10.1172/jci.insight.140329 · Cited by 309

Cytokine Storm—Definition, Causes, and Implications

Jarczak, D., & Nierhaus, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911740 · Cited by 336

Epigenetic memory of coronavirus infection in innate immune cells and their progenitors

Cheong, J.-G., Ravishankar, A., Sharma, S., Parkhurst, C. N., Grassmann, S. A., Wingert, C. K., Laurent, P., Ma, S., Paddock, L., Miranda, I. C., et al. (2023) · Cell · doi:10.1016/j.cell.2023.07.019 · Cited by 309

An integrative drug repositioning framework discovered a potential therapeutic agent targeting COVID-19

Ge, Y., Tian, T., Huang, S., Wan, F., Li, J., Li, S., Wang, X., Yang, H., Hong, L., Wu, N., et al. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00568-6 · Cited by 300

An aberrant STAT pathway is central to COVID-19

Matsuyama, T., Kubli, S. P., Yoshinaga, S. K., Pfeffer, K., & Mak, T. W. (2020) · Cell Death and Differentiation · doi:10.1038/s41418-020-00633-7 · Cited by 295

Functional and genetic analysis of viral receptor ACE2 orthologs reveals a broad potential host range of SARS-CoV-2

Liu, Y., Hu, G., Wang, Y., Ren, W., Zhao, X., Ji, F., Zhu, Y., Feng, F., Gong, M., Ju, X., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2025373118 · Cited by 247

COVID-19 severity associates with pulmonary redistribution of CD1c+ DCs and inflammatory transitional and nonclassical monocytes

Sánchez‐Cerrillo, I., Landete, P., Orzaiz, B. A., Sánchez‐Alonso, S., Sánchez-Azofra, A., Marcos‐Jiménez, A., Ávalos, E., Alcaraz‐Serna, A., Santos, I. D. L., Mateu‐Albero, T., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci140335 · Cited by 250

Chemokines and chemokine receptors during COVID-19 infection

Khalil, B. A., Elemam, N. M., & Maghazachi, A. A. (2021) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2021.01.034 · Cited by 248

Laboratory findings in COVID-19 diagnosis and prognosis

Pourbagheri‐Sigaroodi, A., Bashash, D., Fateh, F., & Abolghasemi, H. (2020) · Clinica Chimica Acta · doi:10.1016/j.cca.2020.08.019 · Cited by 250

Microbiota Modulation of the Gut-Lung Axis in COVID-19

de Oliveira, G. L. V., Oliveira, C. N. S., Pinzan, C. F., de Salis, L. V. V., & Cardoso, C. R. D. B. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.635471 · Cited by 242

Vascular Disease and Thrombosis in SARS-CoV-2-Infected Rhesus Macaques

Aid, M., Busman-Sahay, K., Vidal, S. J., Maliga, Z., Bondoc, S., Starke, C., Terry, M., Jacobson, C. A., Wrijil, L., Ducat, S., et al. (2020) · Cell · doi:10.1016/j.cell.2020.10.005 · Cited by 215

Detection profile of SARS‐CoV‐2 using RT‐PCR in different types of clinical specimens: A systematic review and meta‐analysis

Bwire, G. M., Majigo, M. V., Njiro, B. J., & Mawazo, A. (2020) · Journal of Medical Virology · doi:10.1002/jmv.26349 · Cited by 234

The Innate Immune System: Fighting on the Front Lines or Fanning the Flames of COVID-19?

McKechnie, J. L., & Blish, C. A. (2020) · Cell Host & Microbe · doi:10.1016/j.chom.2020.05.009 · Cited by 218

Natural history of COVID-19 and current knowledge on treatment therapeutic options

dos Santos, W. G. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110493 · Cited by 235

On the whereabouts of SARS-CoV-2 in the human body: A systematic review

Trypsteen, W., Van Cleemput, J., Snippenberg, W. V., Gerlo, S., & Vandekerckhove, L. (2020) · PLOS Pathogens · doi:10.1371/journal.ppat.1009037 · Cited by 199

Clinical and translational values of spatial transcriptomics

Zhang, L., Chen, D., Song, D., Liu, X., Zhang, Y., Xu, X., & Wang, X. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00960-w · Cited by 215

Single-cell analysis of two severe COVID-19 patients reveals a monocyte-associated and tocilizumab-responding cytokine storm

Guo, C., Li, B., Ma, H., Wang, X., Cai, P., Yu, Q., Zhu, L., Jin, L., Jiang, C., Fang, J., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-17834-w · Cited by 203

Overview: Systemic Inflammatory Response Derived From Lung Injury Caused by SARS-CoV-2 Infection Explains Severe Outcomes in COVID-19

Polidoro, R. B., Hagan, R. S., Santiago, R. R. D. S., & Schmidt, N. W. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01626 · Cited by 208

COVID-19 Patients Upregulate Toll-like Receptor 4-mediated Inflammatory Signaling That Mimics Bacterial Sepsis

Sohn, K. M., Lee, S., Kim, H. J., Cheon, S., Jeong, H., Lee, J.-Y., Kim, I. S., Silwal, P., Kim, Y. J., Paik, S., et al. (2020) · Journal of Korean Medical Science · doi:10.3346/jkms.2020.35.e343 · Cited by 199

COVID-19: The Potential Treatment of Pulmonary Fibrosis Associated with SARS-CoV-2 Infection

Lechowicz, K., Drożdżal, S., Machaj, F., Rosik, J., Szostak, B., Zegan-Barańska, M., Biernawska, J., Dąbrowski, W., Rotter, I., & Kotfis, K. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9061917 · Cited by 219

Attenuated Interferon and Proinflammatory Response in SARS-CoV-2–Infected Human Dendritic Cells Is Associated With Viral Antagonism of STAT1 Phosphorylation

Yang, D., Chu, H., Hou, Y., Chai, Y., Shuai, H., Lee, A. C.-Y., Zhang, X., Wang, Y., Hu, B., Huang, X., et al. (2020) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa356 · Cited by 179

Single-cell multi-omics reveals dyssynchrony of the innate and adaptive immune system in progressive COVID-19

Unterman, A., Sumida, T. S., Nouri, N., Yan, X., Zhao, A., Gasque, V., Schupp, J. C., Asashima, H., Liu, Y., Cosme, C., et al. (2022) · Nature Communications · doi:10.1038/s41467-021-27716-4 · Cited by 181

Predictors for Severe COVID-19 Infection

Bhargava, A., Fukushima, E. A., Levine, M. T., Zhao, W., Tanveer, F., Szpunar, S. M., & Saravolatz, L. D. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa674 · Cited by 176

Combined anti-fibrotic and anti-inflammatory properties of JAK-inhibitors on macrophages in vitro and in vivo: Perspectives for scleroderma-associated interstitial lung disease

Lescoat, A., Lelong, M., Jeljeli, M. M., Piquet‐Pellorce, C., Morzadec, C., Ballerie, A., Jouneau, S., Jégo, P., Vernhet, L., Batteux, F., et al. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.114103 · Cited by 181

Hydrogen, a Novel Therapeutic Molecule, Regulates Oxidative Stress, Inflammation, and Apoptosis

Tian, Y., Zhang, Y., Wang, Y. C., Chen, Y., Fan, W., Zhou, J., Qiao, J., & Wei, Y. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.789507 · Cited by 183

High levels of eicosanoids and docosanoids in the lungs of intubated COVID‐19 patients

Archambault, A., Zaid, Y., Rakotoarivelo, V., Turcotte, C., Doré, É., Dubuc, I., Martin, C., Flamand, O., Amar, Y., Cheikh, A., et al. (2021) · The FASEB Journal · doi:10.1096/fj.202100540r · Cited by 169

Immunology of COVID‐19: Mechanisms, clinical outcome, diagnostics, and perspectives—A report of the European Academy of Allergy and Clinical Immunology (EAACI)

Sokołowska, M., Łukasik, Z. M., Agache, I. O., Akdiş, C. A., Akdiş, D., Akdiş, M., Barcik, W., Brough, H. A., Eiwegger, T., Eljaszewicz, A., et al. (2020) · Allergy · doi:10.1111/all.14462 · Cited by 170

Neutrophils and COVID-19: The road so far

Silva, L. H. A. C., Carvalho, D. C. M., Lima, É. D. A., Galvão, J. G. F. M., da Silva, J. S. D. F., de Sales-Neto, J. M., & Rodrigues‐Mascarenhas, S. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.107233 · Cited by 173

Neutrophils in respiratory viral infections

Johansson, C., & Kirsebom, F. C. M. (2021) · Mucosal Immunology · doi:10.1038/s41385-021-00397-4 · Cited by 172

Cellular and Molecular Pathways of COVID-19 and Potential Points of Therapeutic Intervention

Hussman, J. P. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.01169 · Cited by 166

COVID-19 therapeutics: Challenges and directions for the future

Robinson, P. C., Liew, D. F. L., Tanner, H. L., Grainger, J. R., Dwek, R. A., Reisler, R. B., Steinman, L., Feldmann, M., Ho, L., Hussell, T., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2119893119 · Cited by 158

The noncoding and coding transcriptional landscape of the peripheral immune response in patients with COVID‐19

Tang, H., Gao, Y., Li, Z., Miao, Y., Huang, Z., Liu, X., Xie, L., Li, H., Wen, W., Zheng, Y., et al. (2020) · Clinical and Translational Medicine · doi:10.1002/ctm2.200 · Cited by 157

SARS-CoV-2: characteristics and current advances in research

Yang, Y., Xiao, Z., Ye, K., He, X., Sun, B., Qin, Z., Yu, J., Yao, J., Wu, Q., Bao, Z., et al. (2020) · Virology Journal · doi:10.1186/s12985-020-01369-z · Cited by 168

COVID-19: Complement, Coagulation, and Collateral Damage

Lo, M. W., Kemper, C., & Woodruff, T. M. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.2000644 · Cited by 160

Endothelial injury and thrombotic microangiopathy in COVID-19: Treatment with the lectin-pathway inhibitor narsoplimab

Rambaldi, A., Gritti, G., Micò, M. C., Frigeni, M., Borleri, G., Salvi, A., Landi, F., Pavoni, C., Sonzogni, A., Gianatti, A., et al. (2020) · Immunobiology · doi:10.1016/j.imbio.2020.152001 · Cited by 157

Comprehensive transcriptomic analysis of COVID-19 blood, lung, and airway

Daamen, A. R., Bachali, P., Owen, K. A., Kingsmore, K. M., Hubbard, E. L., Labonte, A. C., Robl, R. D., Shrotri, S., Grammer, A. C., & Lipsky, P. E. (2021) · Scientific Reports · doi:10.1038/s41598-021-86002-x · Cited by 151

A Detailed Overview of Immune Escape, Antibody Escape, Partial Vaccine Escape of SARS-CoV-2 and Their Emerging Variants With Escape Mutations

Chakraborty, C., Sharma, A. R., Bhattacharya, M., & Lee, S. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.801522 · Cited by 154

Covid-19: Perspectives on Innate Immune Evasion

Taefehshokr, N., Taefehshokr, S., Hemmat, N., & Heit, B. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.580641 · Cited by 152

Profiling COVID-19 pneumonia progressing into the cytokine storm syndrome: Results from a single Italian Centre study on tocilizumab versus standard of care

Quartuccio, L., Sonaglia, A., McGonagle, D., Fabris, M., Peghin, M., Pecori, D., Monte, A. D., Bove, T., Curcio, F., Bassi, F., et al. (2020) · Journal of Clinical Virology · doi:10.1016/j.jcv.2020.104444 · Cited by 145

Lymphopenia an important immunological abnormality in patients with COVID‐19: Possible mechanisms

Jafarzadeh, A., Jafarzadeh, S., Nozari, P., Mokhtari, P., & Nemati, M. (2020) · Scandinavian Journal of Immunology · doi:10.1111/sji.12967 · Cited by 155

The four horsemen of a viral Apocalypse: The pathogenesis of SARS-CoV-2 infection (COVID-19)

Domingo, P., Mur, I., Pomar, V., Corominas, H., Casademont, J., & Benito, N. (2020) · EBioMedicine · doi:10.1016/j.ebiom.2020.102887 · Cited by 174

Cell-Type-Specific Immune Dysregulation in Severely Ill COVID-19 Patients

Yao, C., Bora, S. A., Parimon, T., Zaman, T., Friedman, O., Palatinus, J. A., Surapaneni, N. S., Matusov, Y. P., Chiang, G. C., Kassar, A. G., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.108590 · Cited by 145

SARS-CoV-2 productively infects primary human immune system cells in vitro and in COVID-19 patients

Pontelli, M. C., Castro, Í. A., Júnior, R. B. M., Serra, L. L., Veras, F. P., Nascimento, D. C., Silva, C. M. S., Cardoso, R. D. S., Rosales, R., Gomes, R., et al. (2022) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjac021 · Cited by 141

Evaluation of the immunogenicity of prime-boost vaccination with the replication-deficient viral vectored COVID-19 vaccine candidate ChAdOx1 nCoV-19

Graham, S. P., McLean, R. K., Spencer, A. J., Belij‐Rammerstorfer, S., Wright, D., Ulaszewska, M., Edwards, J. C., Hayes, J. W. P., Martini, V., Thakur, N., et al. (2020) · npj Vaccines · doi:10.1038/s41541-020-00221-3 · Cited by 138

The Role of Cytokines and Chemokines in Severe Acute Respiratory Syndrome Coronavirus 2 Infections

Hsu, R., Yu, W.-C., Peng, G.-R., Ye, C.-H., Hu, S., Chong, P. C. T., Yap, K. Y., Lee, J. Y. C., Lin, W., & Yu, S. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.832394 · Cited by 148

Xuanfei Baidu Decoction reduces acute lung injury by regulating infiltration of neutrophils and macrophages via PD-1/IL17A pathway

Wang, Y., Wang, X., Li, Y., Xue, Z., Shao, R., Li, L., Zhu, Y., Zhang, H., & Yang, J. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106083 · Cited by 139

The cytokine storm in COVID-19: Further advances in our understanding the role of specific chemokines involved

Coperchini, F., Chiovato, L., Ricci, G., Croce, L., Magri, F., & Rotondi, M. (2021) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2020.12.005 · Cited by 135

The Pro-Inflammatory Chemokines CXCL9, CXCL10 and CXCL11 Are Upregulated Following SARS-CoV-2 Infection in an AKT-Dependent Manner

Callahan, V., Hawks, S. A., Crawford, M. A., Lehman, C. W., Morrison, H. A., Ivester, H. M., Akhrymuk, I. V., Boghdeh, N. A., Flor, R., Finkielstein, C. V., et al. (2021) · Viruses · doi:10.3390/v13061062 · Cited by 137

2D MXenes with antiviral and immunomodulatory properties: A pilot study against SARS-CoV-2

Ünal, M. A., Bayrakdar, F., Fusco, L., Beşbinar, Ö., Shuck, C. E., Yalçın, S., Erken, M. T., Özkul, A., Gürcan, C., Panatli, O., et al. (2021) · Nano Today · doi:10.1016/j.nantod.2021.101136 · Cited by 138

Multi-species single-cell transcriptomic analysis of ocular compartment regulons

Gautam, P., Hamashima, K., Chen, Y., Zeng, Y., Makovoz, B., Parikh, B. H., Lee, H. Y., Lau, K. A., Su, X., Wong, R. C. B., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-25968-8 · Cited by 128

Maternal SARS-CoV-2 infection elicits sexually dimorphic placental immune responses

Bordt, E. A., Shook, L. L., Atyeo, C. G., Pullen, K. M., Guzman, R. M. D., Meinsohn, M.-C., Chauvin, M. Y., Fischinger, S., Yockey, L. J., James, K. E., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abi7428 · Cited by 135

Lymphopenia Caused by Virus Infections and the Mechanisms Beyond

Guo, Z., Zhang, Z., Prajapati, M., & Li, Y. (2021) · Viruses · doi:10.3390/v13091876 · Cited by 141

Disharmonic Inflammatory Signatures in COVID-19: Augmented Neutrophils’ but Impaired Monocytes’ and Dendritic Cells’ Responsiveness

Paračková, Z., Zentsová, I., Bloomfield, M., Vrabcová, P., Smetanová, J., Klocperk, A., Mesežnikov, G., Méndez, L. F. C., Vymazal, T., & Šedivá, A. (2020) · Cells · doi:10.3390/cells9102206 · Cited by 129

The SARS-CoV-2 Cytopathic Effect Is Blocked by Lysosome Alkalizing Small Molecules

Gorshkov, K., Chen, C. Z., Bostwick, R. J., Rasmussen, L. A., Tran, B. N., Cheng, Y.-S., Xu, M., Pradhan, M., Henderson, M. J., Zhu, W., et al. (2020) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.0c00349 · Cited by 132

COVID-19 Hyperinflammation: What about Neutrophils?

Didangelos, A. (2020) · mSphere · doi:10.1128/msphere.00367-20 · Cited by 125

Cytokine Storm in COVID-19: “When You Come Out of the Storm, You Won’t Be the Same Person Who Walked in”

Castelli, V., Cimini, A., & Ferri, C. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.02132 · Cited by 129

The role of cysteine peptidases in coronavirus cell entry and replication: The therapeutic potential of cathepsin inhibitors

Pišlar, A. H., Mitrović, A., Sabotič, J., Fonović, U. P., Nanut, M. P., Jakoš, T., Senjor, E., & Kos, J. (2020) · PLoS Pathogens · doi:10.1371/journal.ppat.1009013 · Cited by 124

Inferring microenvironmental regulation of gene expression from single-cell RNA sequencing data using scMLnet with an application to COVID-19

Cheng, J., Zhang, J., Wu, Z., & Sun, X. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbaa327 · Cited by 125

Evidence and possible mechanisms of rare maternal-fetal transmission of SARS-CoV-2

Egloff, C., Vauloup‐Fellous, C., Picone, O., Mandelbrot, L., & Roques, P. (2020) · Journal of Clinical Virology · doi:10.1016/j.jcv.2020.104447 · Cited by 127

Neurobiology of SARS-CoV-2 interactions with the peripheral nervous system: implications for COVID-19 and pain

McFarland, A. J., Yousuf, M. S., Shiers, S. I., & Price, T. J. (2021) · PAIN Reports · doi:10.1097/pr9.0000000000000885 · Cited by 124

The trans-omics landscape of COVID-19

Wu, P., Chen, D., Ding, W., Wu, P., Hou, H., Bai, Y., Zhou, Y., Li, K., Xiang, S., Liu, P., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-24482-1 · Cited by 122

The potential of JAK/STAT pathway inhibition by ruxolitinib in the treatment of COVID-19

Bağca, B. G., & Avcı, Ç. B. (2020) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2020.06.013 · Cited by 119

The SARS-CoV-2 subgenome landscape and its novel regulatory features

Wang, D., Jiang, A., Feng, J., Li, G., Guo, D., Sajid, M., Wu, K., Zhang, Q., Ponty, Y., Will, S., et al. (2021) · Molecular Cell · doi:10.1016/j.molcel.2021.02.036 · Cited by 119

Neutrophilia and NETopathy as Key Pathologic Drivers of Progressive Lung Impairment in Patients With COVID-19

Narasaraju, T., Tang, B. M. P., i, M. H., Muller, S., Chow, V. T. K., & Radic, M. Z. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00870 · Cited by 116

Mutations of SARS-CoV-2 spike protein: Implications on immune evasion and vaccine-induced immunity

Mengist, H. M., Kombe, A. J. K., Mekonnen, D. S., Abebaw, A., Getachew, M., & Jin, T. (2021) · Seminars in Immunology · doi:10.1016/j.smim.2021.101533 · Cited by 115

The roles of APOBEC-mediated RNA editing in SARS-CoV-2 mutations, replication and fitness

Kim, K., Calabrese, P., Wang, S., Qin, C., Rao, Y., Feng, P., & Chen, X. S. (2022) · Scientific Reports · doi:10.1038/s41598-022-19067-x · Cited by 115

Dysregulated transcriptional responses to SARS-CoV-2 in the periphery

McClain, M. T., Constantine, F. J., Henao, R., Liu, Y., Tsalik, E. L., Burke, T. W., Steinbrink, J. M., Petzold, E., Nicholson, B. P., Rolfe, R. J., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-21289-y · Cited by 112

Innate immunity during SARS-CoV-2: evasion strategies and activation trigger hypoxia and vascular damage

Amor, S., Blanco, L. F., & Baker, D. (2020) · Clinical & Experimental Immunology · doi:10.1111/cei.13523 · Cited by 114

Immune and Metabolic Signatures of COVID-19 Revealed by Transcriptomics Data Reuse

Gardinassi, L. G., Souza, C. O. S., Sales‐Campos, H., & Fonseca, S. G. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01636 · Cited by 112

Nebulised heparin as a treatment for COVID-19: scientific rationale and a call for randomised evidence

van Haren, F. M. P., Page, C. P., Laffey, J. G., Artigas, A., Camprubí–Rimblas, M., Nunes, Q. M., Smith, R. J., Shute, J. K., Carroll, M., Tree, J. A., et al. (2020) · Critical Care · doi:10.1186/s13054-020-03148-2 · Cited by 114

NK cells: A double edge sword against SARS-CoV-2

Masselli, E., Vaccarezza, M., Carubbi, C., Pozzi, G., Presta, V., Mirandola, P., & Vitale, M. (2020) · Advances in Biological Regulation · doi:10.1016/j.jbior.2020.100737 · Cited by 110

Transcriptomic analysis of COVID‑19 lungs and bronchoalveolar lavage fluid samples reveals predominant B cell activation responses to infection

Cavalli, E., Petralia, M. C., Basile, M. S., Bramanti, A., Bramanti, P., Nicoletti, F., Spandidos, D. A., Shoenfeld, Y., & Fagone, P. (2020) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2020.4702 · Cited by 37

Transcriptomic dysregulations associated with SARS-CoV-2 infection in human nasopharyngeal and peripheral blood mononuclear cellsPreprint

de Melo, C. V. B., Bhuiyan, M. A., Gatua, W., Kanyerezi, S., Uzairue, L. I., Abechi, P., Kumar, K., Rahmat, J., Giwa, A. O., Mwandira, G., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.09.09.289850 · Cited by 2

Immune transcriptomic analysis on COVID-19 patients with varying clinical presentations identifies severity markers

Abdallah, A. M., Ansari, H., Shuaib, M., Doudin, A., Yassine, H. M., Shah, S. S. U. D., Mir, F., Emara, M., Elzouki, A.-N., & Cyprian, F. (2025) · Scientific Reports · doi:10.1038/s41598-025-04837-0 · Cited by 1

Heightened Innate Immune Responses in the Respiratory Tract of COVID-19 Patients

Zhou, Z. L., Ren, L., Zhang, L., Zhong, J., Xiao, Y., Jia, Z., Guo, L., Yang, J., Wang, C., Jiang, S., et al. (2020) · Cell Host & Microbe · doi:10.1016/j.chom.2020.04.017 · Cited by 980

Immune and Metabolic Signatures of COVID-19 Revealed by Transcriptomics Data Reuse

Gardinassi, L. G., Souza, C. O. S., Sales‐Campos, H., & Fonseca, S. G. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01636 · Cited by 112